SMi Group's Prefilled Syringes West Coast 2019 conference takes place in San Diego in June

1. PLUS ONE INTERACTIVE HALF-DAY POST-CONFERENCE WORKSHOP
WEDNESDAY 5TH JUNE 2019, HYATT REGENCY MISSION BAY, SAN DIEGO, CA, USA
www.prefilled-syringes-westcoast.com
Register online or fax your registration to +44 (0) 870 9090 712
or call +44 (0) 870 9090 711
ACADEMIC & GROUP DISCOUNTS AVAILABLE
SPONSORED BY
SMi Group Presents the 4th Annual Conference and Exhibition…
Hyatt Regency Mission Bay, San Diego, CA, USA
CONFERENCE:
3RD - 4TH
JUNE
2019WORKSHOP: 5TH
Pre-Filled Syringes
West Coast
Assessing Device Development Strategies
and Regulation for Enhanced Innovation
The Secrets to Uncovering and Addressing Design Flaws BEFORE Usability Testing
Workshop Leader: Shannon Clark, Principal, UserWise, Inc.
08.30 - 12.00
SMi Pharma
@SMiPharm
#smipfsusa
CO-CHAIRS FOR 2019:
• Michael Song, Senior Manager, Dosage Form Design and Development,
MedImmune
• Tina Rees, Associate Director - Human Factors, Ferring Pharmaceuticals
LEADING PHARMACEUTICAL SPEAKERS:
• Bejamin Werner, Scientist, Pharmaceutical Development Biologicals,
Boehringer Ingelheim
• Diane Doughty, Senior Scientist, MedImmune
• Ed Israelski, Consultant - Technical Advisor on Human Factors,
Retired Director Human Factors, AbbVie
• Jason E. Fernandez, Senior Scientist, Protein Pharmaceutical
Development, Biogen
• Lin Li, Senior Consultant Engineer, Eli Lilly and Company
• Lori Burton, Senior Principal Scientist, Bristol-Myers Squibb
• Ronald Forster, Director Process Development, Amgen
• Swapnil Pansare, Scientist, Dosage Form Design and Development,
MedImmune
NEW FOR 2019:
• Explore the latest innovations in digital technology, enhancing the
patient experience through mobile applications, software-based
medical devices and advances in connectivity
• Navigate through the recent updates in the PFS regulatory environment
with an FDA perspective and industry perspectives as well as a panel
discussion forecasting the future trends
• Assess on emerging approaches to device development from leading
pharmaceutical companies including Eli Lilly, Amgen and MedImmune
• Delve into the latest research and case studies exploring the key
challenges in formulation for combination products
BOOK BY 28TH FEBRUARY AND SAVE $400
BOOK BY 29TH MARCH AND SAVE $200
BOOK BY THE 30TH APRIL AND SAVE $100

2. LETTER FROM THE CHAIRS:
Dear Participants,
It is with great pleasure and delight that we welcome each of you to SMi’s
2019 Pre-Filled Syringe West Coast conference in San Diego, California
Over the past decade, pre-filled syringe venues have grown significantly
in terms of content and attendance as the pre-filled syringe market
and pharmaceutical interest in pre-filled syringe continues to grow. The
prefilled syringe market is projected to grow an additional 10.5% by 2024
with continually increasing number of drug products being developed
and administered via prefilled syringe.
Prefilled syringe offers many unique benefits and can be easily integrated
within drug delivery devices for patient self-administration. These products
have undoubtedly improved the lives of countless patients and caregivers
who administer the medication but are not without challenges. As such, as
an industry, we have a duty to further develop and evolve these products
to meet and/or exceed the needs of our patients and improve upon
therapeutic options through the sharing of lessons learned, experiences,
and scientific breakthroughs.
The meeting will allow for the face-to-face convergence of subject matter
experts, thought leaders, researchers, and manufacturers in disciplines
related to the development of prefilled syringes and other therapeutic
delivery products, and thereby provide a tremendous opportunity for
meaningful discourse.
We look forward to seeing you there!
Michael Song, Senior Manager, Dosage Form Design
and Development, MedImmune
Tina Rees, Associate Director - Human Factors,
Ferring Pharmaceuticals
08.30 Registration & Coffee
08.50 Co-chairs Opening Remarks
Michael Song, Senior Manager, Dosage Form Design and
Development, MedImmune
Tina Rees, Associate Director - Human Factors, Ferring
Pharmaceuticals
13.10 Networking LunchPLATFORM APPROACHES AND DEVICE DEVELOPMENT INNOVATIONS
OPENING ADDRESS
09.00 Platform approach for combination products and devices
• HFE assessment considerations
• Challenges in biocompatibility
• The balance between volume and viscosity
• The future of the platform approach for devices
Ron Forster, Executive Director, Amgen
09.35 Elastomeric Components: Supporting Next Generation Drug
Delivery Systems
• How can innovation in elastomeric components support PFS &
next generation drug delivery systems?
• How can a suppliers manufacturing network support PFS & next
generation drug delivery systems?
• What can we learn from other industries and apply it to future
innovations and support drug delivery innovations?
Douglas Cusato, Director of Medical Rubber Business,
Sumitomo Rubber North America
10.15 Innovative Application of Computer Aided Engineering in
Development of Pharmaceutical Packaging
• Simulation led design
• Device mechanism optimization
• Container closure integrity at various shipping condition
• Injection Physiology
Lin Li, Senior Consultant Engineer, Eli Lilly and Company
10.50 Morning Coffee Sponsored by
11.20 Multilayer plastic syringe with excellent oxygen and UV barrier
• Excellent oxygen and UV barrier contribute to stability of
biologics
• Optimized silicone-oil contributes to preventing protein
aggregation
• Extremely low levels of extractables contribute to stability of
biologics
• Development of staked needle syringes
Hiroki Hasegawa, Researcher, Mitsubishi Gas Chemical
Company, Inc.
12.00 Development of user-centric requirements for
pre-filled syringes and injection devices
• Review of user-centric device characteristics
• Generating user-relevant design input requirements
• Applying a platform approach to user-centric devices
Diane Doughty, Senior Scientist, MedImmune
12.35 Networking Lunch
13.10 Networking LunchIMPROVING HUMAN FACTORS FOR ENHANCED PATIENT CENTRICITY – PART 1
13.35 Human Factors Guidelines for Mobile Health Applications
• Background on development process
• Guidelines content review
• Details on development and application of usability guidelines
• Practical ways to apply guidelines to development
Natalie Abts, Senior Program Manager, Usability Services,
National Center for Human Factors in Health Care, MedStar Health
14.10 Digital Health, considerations when developing digital
connectivity solutions
• Explore the use of wireless communication systems beyond
Bluetooth
• Explore advantages and disadvantages between using
add-on vs. add-in
• How much data is enough data
• Regulatory considerations and challenges
Michael Song, Senior Manager, Dosage Form Design and
Development, MedImmune
14.45 FDA Training Decay Research Initiative
– Is a 1-hour training decay long enough for
summative usability testing?
• Identify differences in decay between device types
• The effects of accelerated decay
• Assessing the task-training decay curve profiles
• Identify generalizable detailed training decay curves
Shannon Clark, Principal, UserWise, Inc.
15.20 Afternoon Tea Sponsored by
13.10 Networking LunchA REGULATORY OUTLOOK
PANEL DISCUSSION
15.50 Future Regulatory Trends
• The European Medical Device Regulation
• The emerging market in China
• Brexit and how it will effect the device industry
• Regulatory strategies for wearables, software-based medical
devices and integrated devices
Moderator:
Ronald Forster, Director Process Development, Amgen
Panel Members:
Natalie Abts, Senior Program Manager, Usability Services,
National Center for Human Factors in Health Care, MedStar Health
Gay Steinbrick, Regulatory and Safety Expert, Managing Partner,
gMedicas. Formerly, Lead, Medical Device and Combination
Product, Global Safety, Merck & Co
16.25 Overview of EU MDR specific to safety
• Overview of requirements for EU MDR
• Discuss new requirements for post-market surveillance
• Integration of post-market surveillance activities with risk
management and clinical evaluation
Gay Steinbrick, Regulatory and Safety Expert, Managing Partner,
gMedicas. Formerly, Lead, Medical Device and Combination
Product, Global Safety, Merck & Co
17.00 Co-Chair’s Closing Remarks and Close of Day One
18.00 - 20.00 End of Day One Dinner Hosted by Sponsors
Limited availability - Only available to pharma companies
Pre-Filled Syringes West Coast
DAY ONE | MONDAY 3RD JUNE 2019 www.prefilled-syringes-westcoast.com
Register online at www.prefilled-syringes-westcoast.com
Engage with top pharma scientists and
engineers in our PFS focused conference
Hear the very latest plans for drug-delivery
development in the injectables industry
Network with industry and pharma leaders
in the exhibition area

3. Pre-Filled Syringes West Coast
DAY TWO | TUESDAY 4TH JUNE 2019 www.prefilled-syringes-westcoast.com
Alternatively fax your registration to +44 (0)870 9090 712 or call +44 (0)870 9090 711
08.30 Registration & Coffee
08.50 Co-chairs Opening Remarks
Michael Song, Senior Manager, Dosage Form Design and
Development, MedImmune
Tina Rees, Associate Director - Human Factors, Ferring
Pharmaceuticals
IMPROVING HUMAN FACTORS FOR ENHANCED PATIENT CENTRICITY – PART 2
OPENING ADDRESS
09.00 Digital health applications
• Mobile applications that support drug delivery
• The benefits of digital health and patient compliance
• User interface developments
• Advances in connectivity
Ed Israelski, Consultant – Technical Advisor on Human Factors,
Retired Director Human Factors, AbbVie
09.35 Pain perception and injection devices: could pain be assessed
through non-human person trials in early stage device
development?
• Pain perception key drivers during injection
• Can a study on NHP evaluate pain associated to injection?
• Application of NHP model on testing customization and
technical improvements on injection devices to limit pain
Severine Duband, Global Category Manager, Nemera
10.10 Human Factor considerations for pre-filled syringes
• New product design and development
• Approaching a regulatory submission
• Advancements in human factors for pre-filled syringes
• Considerations for patient centricity
Tina Rees, Associate Director - Human Factors,
Ferring Pharmaceuticals
10.45 Morning Coffee Sponsored by
11.15 Session reserved for Kaleidoscope Innovation
Speaker details to be confirmed
PANEL DISCUSSION
11.55 Improving patient centricity through digital health
• Optimising user interface tools
• How to improve patient compliance
• Overcoming cyber security challenges
• The benefits of digital health and patient compliance
Moderator:
Ed Israelski, Consultant – Technical Advisor on Human Factors,
Retired Director Human Factors, AbbVie
Panel Members:
Lin Li, Senior Consultant Engineer, Eli Lilly
Diane Doughty, Senior Scientist, MedImmune
FORMULATION AND CONTAINMENT CONSIDERATIONS
12.30 Viscosity Challenges for Design and Development of
Combination products for Subcutaneous Administration
• Combination products (i.e., accessorized prefilled syringes and
autoinjector) for SC administration have different requirements
for maximum viscosity to meet the device functionality (i.e.
glide force & injection time) criteria
• Protein formulations may show shear thinning behaviour
(i.e. decrease in viscosity as shear rate increases), thereby
impacting device functionality
• Viscosity limit for combination products was significantly higher
due to shear thinning observed for protein formulations
Swapnil Pansare, Scientist, Dosage Form Design and
Development, MedImmune
13.05 Networking Lunch
14.05 Technical updates in Cyclo Olefin Polymer (COP)
– A Case Study
• Key Properties of COP
• Case study: Biologics formulation for COP syringe optimized
to eliminating use of surfactant
• Case study: Study on Protein adsorption/aggregation
– COP vs glass
• Case study: Study on delamination with glass syringe
vs COP syringe
• Leachable data on COP syringes with various chemicals
Toshiro Katayama, Product Manager, Speciality Plastics,
Zeon Chemicals L.P
14.45 Impact of silicone oil free polymer syringes on therapeutic
proteins
• Advantages and disadvantages of glass and polymer syringes
• Long-term protein stability for polymer systems
• Oxygen permeation of polymer syringes
• Nitrogen filled pouches for polymer syringe storage
Bejamin Werner, Scientist, Pharmaceutical Development
Biologicals, Boehringer Ingelheim
15.20 Afternoon Tea Sponsored by
15.50 Drug Product Development Considerations
for Subcutaneous Delivery of Proteins
• There are a number of considerations when developing
protein drug products for subcutaneous delivery, this talk
will highlight some common considerations:
- Managing the viscosity of liquid formulations for high
concentration products
- Drug product manufacturing parameter development for
SC administered products
- Managing subcutaneous primary container compatibility
and interactions with protein formulations for SC delivery
Jason E. Fernandez, Senior Scientist, Protein Pharmaceutical
Development, Biogen
16.25 Understanding and Controlling the Risk of Protein Aggregation in
Siliconized Pre-Filled Syringes
• Biologics products, packaged in pre-filled syringes, can
sometimes show physical instability due to the silicone oil used
to lubricate the syringe barrel
• The nature of the interaction between proteins and silicone oil
will be reviewed
• The common approaches for understanding and mitigating
this risk
Lori Burton, Senior Principal Scientist, Bristol-Myers Squibb
17.00 Co-Chair’s Closing Remarks and Close of Day Two
SMI’S UPCOMING
EVENTS IN
THE PRE-FILLED
SYRINGES SERIES:
PRE-FILLED SYRINGES
EAST COAST
8TH-9TH APRIL 2019,
BOSTON, USA
INJECTABLE DRUG
DELIVERY
15TH-16TH MAY 2019,
LONDON, UK
• Advanced Molding Technologies
• Aegerion Pharmaceuticals
• Ajinomoto Althea, Inc.
• Allergan
• Almac Group
• Amgen
• Antares Pharma
• Aptar Pharma
• Baxter Healthcare
• BCM Group LLC
• BioMarin
• Connecticut Spring & Stamping
• Credence MedSystems
• Dexcom
• Execution Metrics, Inc
• Ferring Pharmaceuticals
• Fresenius-Kabi
• Genentech
• Gilead Sciences
• Glenmark Pharmaceuticals
• Harro Hofliger
Verpackungsmaschinen GmbH
• Inovio Pharmaceuticals
• iO Lifesciences
• Ionis Pharmaceuticals
• MedImmune
• Medizap
• Medtronic
• Mitsubishi Gas Chemical Company
• Nemera
• Nipro PharmaPackaging
• Novartis
• NOVO Engineering, Inc.
• One World DMG
• Owen Mumford
• Pfenex
• RAUMEDIC INC
• Regeneron
• Shire
• Smithers Rapra
• Steri-Tek
• Stevanato Group S.p.A
• Subcuject ApS
• Suttons Creek Inc
• Terumo Corporation
• UserWise, Inc.
• W. L. Gore & Associates, Inc.
• West Pharmaceuticals
Services Inc
• Worrell
• Xeris Pharmaceuticals
• Zebrasci inc
• ZEON Corporation
PRE-FILLED SYRINGES WEST COAST ATTENDEE LIST

4. Workshop Leader:
Shannon Clark, Principal,
UserWise, Inc.
The Secrets to Uncovering and Addressing Design Flaws BEFORE Usability Testing
Programme
8.30 Registration and Coffee
9.00 Opening remarks and introductions
9.10 Principles of Design
• What are the guiding principles of designing
a new medical product or selecting a drug
delivery device for your new drug?
• How do I conduct an expert review to uncover
design flaws even before entering into usability
testing?
9.50 Good vs. Bad Design
• Study numerous examples of Good vs. Bad
Design and start training delegates to see the
patterns of good vs. bad design
• Review the principles of comparative expert
reviews - How do I select the best drug delivery
platform for my product?
• Review the principles of informal use error
analysis, IEC 62366 PCA task analysis, and use-
related risk analysis to uncover use errors
10.30 Morning Coffee and Networking Break
11.00 Interactive Expert Reviews
• Delegates will be presented with different real-
life medical product prototypes and concepts,
and they’ll be tasked with conducting an expert
review
• Discuss the principles of identifying whether the
product is “optimized” and ready for testing
11.40 Closing Remarks from Workshop Leader
12.00 End of Workshop
Workshop Overview
Workshop attendees will learn
1. Principles of design that are key for developing
medical products or selecting drug delivery
devices for new drugs, and
2. Best practices for how to conduct an expert
review to uncover design flaws even before
entering into usability testing.
A review will be presented on numerous examples
of Good vs. Bad Design and delegates will be
trained on how to best select the drug delivery
platform for a specific product as well as use
principles of informal use error analysis, IEC 62366
PCA task analysis, and use-related risk analysis to
uncover use errors that could negatively impact
usability testing results and ultimate product
success.
Why you should attend
Uncovering design flaws late in the development
cycle can be costly and catastrophic to meeting
a medical product’s commercialization deadline.
Workshop attendees will learn how to uncover
use errors early in the design process to avoid
unacceptable use errors surfacing during late
stage usability testing.
About the workshop leaders
Shannon E. Clark is founder and CEO of
UserWise, a consultancy that helps medical
device manufacturers and
start-ups to design safe and
easy-to-use medical devices.
The consultants at UserWise
conduct usability testing
for a variety of medical
devices ranging from surgical
robots to home-use injection
platforms. UserWise consultants also perform
safety assessments to comply with U.S. and
international regulations related to Human
Factors. Before founding UserWise in 2015,
Shannon was a Human Factors Engineer at
Intuitive Surgical and Abbott Laboratories.
Shannon graduated from UCLA with a B.S.
in Mechanical Engineering and a technical
breadth in Technology Management.
Shannon is additionally a Certified Professional
Industrial Engineer, holds two patents, and has
written and published three books.
About the organisation
UserWise is a team of Human Factors Engineers
dedicated to designing best-in class medical
products, packaging, and labelling. With
experience ranging from home-use injectables
and diagnostics to robotic surgery platforms,
our consultants successfully navigate
medical device and combination product
regulations via usability testing, use-related
risk analysis, and compliance documentation.
www.userwiseconsulting.com
HALF-DAY POST-CONFERENCE WORKSHOP A
WEDNESDAY 5TH JUNE 2019 | 08.30 - 12.00
HYATT REGENCY MISSION BAY, SAN DIEGO, CA, USA
Register online at www.prefilled-syringes-westcoast.com
MARKETING OPPORTUNITIES
Want to know how you can get involved? Interested in promoting your services to this market?
Contact Jinna Sidhu, SMi Marketing on +44 (0) 207 827 6088 or email: hsidhu@smi-online.co.uk
SUPPORTED BYOFFICIAL
MEDIA PARTNERS
Pre-Filled Syringes West Coast - Past Attendee Breakdown
Breakdown by Job Function
110+Industry professionals
from Europe and beyond
8+Dedicated hours
of networking
Breakdown by Geo-Split
USA 77%
Europe 10%
United
Kingdom 7%
Asia
Pacific 6%
C-level 9%
Vice President 3%
Director 17%
Product Manager 15%
Senior Engineer 13%
Senior Device Manager 6%
Senior Principal Scientist 11%
Supply Chain Manager 1%
Quality Assurance 4%
Packaging Expert 3%
Regulatory Affairs 2%
Business Development Manager 16%
Attendee Testimonials:
“ The conference did a good job of
bridging the gap between drug/bio
and device knowledge”

5. PROUDLY SPONSORED BY:
SPONSORSHIP AND EXHIBITION OPPORTUNITIES
SMi offer sponsorship, exhibition, advertising and branding packages, uniquely tailored to compliment you company’s marketing strategy.
Prime networking opportunities exist to entertain, enhance and expand your client base within the context of an independent discussion specific
to your industry. Should you wish to join the increasing number of companies benefiting from sponsoring our conference please call:
Alia Malick on +44 (0) 20 7827 6168 or email: amalick@smi-online.co.uk
Pre-Filled Syringes West Coast
www.prefilled-syringes-westcoast.com
Almac is an established contract development and manufacturing organization that provides an extensive range of integrated services to the
pharmaceutical and biotech sectors globally. From our Audubon, PA facilities, Almac provides innovative commercial packaging solutions built upon
quality & flexibility to support all your packing needs, from niche/orphan drug launches to high volume products. Our specialized packaging solutions for
all biopharmaceutical dosage forms (vials, ampoules, pre-filled syringes, auto-injector pens) includes:
• Pack design and prototype generation • Labeling, assembly and secondary packaging • Complex kit assembly
• Temperature sensitive storage • Serialization
Our wide range of services and flexibility to handle projects of any size, makes us your preferred US packaging partner.
www.almacgroup.com
Aptar Pharma is a leading provider of innovative drug delivery systems to pharmaceutical, consumer healthcare and biotech customers worldwide,
enabling safe, convenient and compliant medication delivery. Trusted partner of the pharmaceutical community, we provide our customers with a large
range of specialized drug delivery devices, components and analytical services backed by decades of proven expertise. We have broad therapeutic
expertise in Nasal, Pulmonary, Injectables, Eye Care and Dermal delivery routes, among others. Our global manufacturing footprint of sites in Argentina,
China, France, Germany, India, Switzerland and the U.S. provides security of supply and local support to our customers. www.aptar.com/pharma
Harro Höfliger is located in Southern Germany with over 1250 employees. With an extensive portfolio of technical platforms, Harro Höfliger
offers customer specific, special solutions for growing market segments, innovative products and new drug delivery systems. Its technology
platforms and turnkey system solutions are always precisely tailored to the needs of the customer. This 100% customer focus and a high level of
innovation have earned the company a leading market position. With a worldwide sales and service network. A member of Excellence United.
www.hoefliger.com
Founded in 1989, Kaleidoscope Innovation is a full-service, insights, design and development firm. Offering consultancy-style and onsite services,
Kaleidoscope Innovation helps business partners solve challenges through: Insights & Human Factors, Industrial Design & User Experience, Engineering,
Visualization and Software Development. Kaleidoscope Innovation has ISO 13485:2016 certification and IEC 60601 compliant. www.kascope.com
Lonstroff is a partner that offers all services related to elastomeric solutions from a single source. We advise our customers not only in the new development
and optimization of materials, but also in their applications and in value analysis. Thanks to our experience, we are also able to provide valuable support
with the registration and approval of the products. www.lonstroff.com
Mitsubishi Gas Chemical is a leading company in the field of oxygen barrier and absorbing technologies. Based on these technologies and experiences,
we have successfully developed multilayer plastic vial and syringe having excellent oxygen and water vapor barrier. The products make it possible to
replace glass with plastic for injectable drugs. www.mgc.co.jp/eng/products/abd/oxycapt.html
Nemera is a world leader in the design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology & generics
industries.Nemeraalwaysputspatientsfirst,providingservicesandproductsforseveralkeydeliveryroutes:Parenteral,Ophthalmic,Nasal,Buccal,Auricular,
Inhalation, Dermal/Transdermal. Nemera leverages decades of experience in the parenteral device segment from full development to pure contract
manufacturing, through customized solutions. Nemera developed: - Safe’n’Sound®, a fully passive safety device for prefilled syringes to avoid accidental
needle-sticks. - Safelia®, a new generation of 2-steps auto-injector for fluid and viscous formulations. www.nemera.net
Plastic Ingenuity is a custom thermoformer that provides packaging for the drug delivery and pharmaceutical markets. We specialize in creating
secondary packaging for pharmaceutical combination products and automation trays that integrate into high volume assembly equipment for our drug
delivery partners. These parts run flawlessly on highly complex automated equipment. www.plasticingenuity.com
Since our founding in 1909 as the first modern rubber factory in Japan, we at Sumitomo Rubber Industries have strived to produce advanced,
environmentally friendly products based on the latest innovations in rubber technology. Within the medical rubber group, we are focused on providing the
highest quality products, and ultimately dedicated to improving the lives of people around the world. Utilizing the latest in material and process innovations
and our global manufacturing footprint, our team members work diligently to ensure we deliver consistent high performing products and provide strong
assurance of supply. http://hybrid.srigroup.co.jp/en/products/cleanrubber/
ZEON’s Zeonex® and Zeonor® cyclo olefin polymer (COP) allow for advanced, break-resistant syringes, vials and lyophilization containers for protein-based
biopharmaceuticals, high viscosity drugs, and contrast media. They also offer high purity, “glass-like” transparency, sterilization, low water absorption, and
superior moldability, as well as overcome protein adsorption and ph shift concerns. www.zeonex.com
With over 160 years of expertise in materials and components testing, ZwickRoell delivers intelligent materials testing solutions for the medical industry,
including drug delivery testing systems for syringes and cartridges, autoinjectors, and pen injectors. Our qualification services help ensure compliance to
your industry’s stringent testing requirements. www.zwickroell.com
Register online at www.prefilled-syringes-westcoast.com
SMi PHARMACEUTICAL EVENT PLANNER 2019
FEBRUARY 2019
Parallel Trade
5th - 6th February 2019, London, UK
3D Cell Culture
20th - 21st February 2019, London, UK
RNA Therapeutics
20th - 21st February 2019, London, UK
MARCH 2019
Superbugs & Superdrugs
18th - 19th March 2019, London, UK
Drug Discovery Chemistry
18th - 19th March 2019, London, UK
APRIL 2019
Adaptive Designs
1st - 2nd April 2019, London, UK
Pre-Filled Syringes East Coast
8th - 9th April 2019, Boston, USA
Pharmaceutical Microbiology East Coast
10th - 11th April 2019, Boston, USA
MAY 2019
Pain Therapeutics
13th - 14th May 2019, London, UK
Highly Potent Active Pharmaceutical
Ingredients
13th - 14th May 2019, London, UK
Injectable Drug Delivery
15th - 16th May 2019, London, UK
JUNE 2019
Prefilled Syringes West Coast
3rd - 4th June 2019, San Diego, USA
Lyophilisation
3rd - 4th June 2019, London, UK
Pharmaceutical Microbiology
West Coast
5th - 6th June 2019, San Diego, USA
SEPTEMBER 2019
Biosimilars & Biobetters
25th - 26th September 2019, London, UK
OCTOBER 2019
Orphan Drugs
15th - 16th October 2019, London, UK
NOVEMBER 2019
Ophthalmic Drugs
18th - 19th November 2019, London, UK

6. PRE-FILLED SYRINGES WEST COAST 2019
Conference: Monday 3rd & Tuesday 4th June 2019, Hyatt Regency Mission Bay, San Diego, CA, USA
Workshop: Wednesday 5th June 2019, Hyatt Regency Mission Bay, San Diego, CA, USA
4 WAYS TO REGISTER
www.prefilled-syringes-westcoast.com
If you have any further queries please call the Events Team on tel +44 (0) 870 9090 711 or you can email events@smi-online.co.uk
EARLY BIRD
DISCOUNT
□ Book by 28th February to receive $400 off the conference price
□ Book by 29th March to receive $200 off the conference price
□ Book by 30th April to receive $100 off the conference price
Payment must be made to SMi Group Ltd, and received before the event, by one of
the following methods quoting reference P-290 and the delegate’s name. Bookings
made within 7 days of the event require payment on booking, methods of payment:
□ UK BACS Account Name: SMi (Group) Ltd
□ Wire Transfer Sort Code: 30-00-09, Account: 11775391
Lloyds TSB Bank Plc, 39 Threadneedle Street, London, EC2R 8AU
Swift (BIC): LOYDGB21013, Account 11775391
IBAN GB75 LOYD 3000 0911 7753 91
□ Cheque We can only accept US Dollar Cheques drawn on a US Bank
□ Credit Card □ Visa □ MasterCard □ American Express
SMi Group will apply surcharges to commercial cards
Please tick here □ if the card provided is not a commercial card
Card No: □□□□ □□□□ □□□□ □□□□
Valid From □□/□□ Expiry Date □□/□□
CVV Number □□□□ 3 digit security on reverse of card, 4 digits for AMEX card
Cardholder’s Name:
Signature: Date:
I agree to be bound by SMi’s Terms and Conditions of Booking.
Card Billing Address (If different from above):
PAYMENT
VAT at 20% is charged on Document portal and literature distribution for all UK customers
and for those EU customers not supplying a registration number for their own country here.
______________________________________________________________________________________
VAT
I cannot attend but would like to purchase access to the following Document
Portal/paper copy documentation Price Total
□ Access to the conference documentation
on the Document Portal £499.00 + VAT £598.80
□ The Conference Presentations – paper copy £499.00 - £499.00
(or only £300 if ordered with the Document Portal)
DOCUMENTATION
CONFERENCE PRICES
I would like to attend: (Please tick as appropriate) Fee
□ Conference & Workshop $2498.00
□ Conference only $1999.00
□ Workshop only $499.00
□ Evening Dinner - Limited availability,
only available to pharmaceutical companies
PROMOTIONAL LITERATURE DISTRIBUTION
□ Distribution of your company’s promotional
literature to all conference attendees $1598 + VAT $1917.60
The conference fee includes refreshments, lunch, conference papers, and access to
the Document Portal. Presentations that are available for download will be subject to
distribution rights by speakers. Please note that some presentations may not be available
for download. Access information for the document portal will be sent to the e-mail
address provided during registration. Details are sent within 24 hours post conference.
Unique Reference Number
Our Reference LVP-290
Please complete fully and clearly in capital letters. Please photocopy for additional delegates.
Title: Forename:
Surname:
Job Title:
Department/Division:
Company/Organisation:
Email:
If you would like to continue to receive email updates about our
events, please tick □
Company VAT Number:
Address:
Town/City:
Post/Zip Code: Country:
Direct Tel: Direct Fax:
Mobile:
Switchboard:
Signature: Date:
I agree to be bound by SMi’s Terms and Conditions of Booking.
ACCOUNTS DEPT
Title: Forename:
Surname:
Email:
Address (if different from above):
Town/City:
Post/Zip Code: Country:
Direct Tel: Direct Fax:
Payment: If payment is not made at the time of booking, then an invoice will be issued and must
be paid immediately and prior to the start of the event. If payment has not been received then
credit card details will be requested and payment taken before entry to the event. Bookings within
7 days of event require payment on booking. Access to the Document Portal will not be given until
payment has been received.
Substitutions/Name Changes: If you are unable to attend you may nominate, in writing, another
delegate to take your place at any time prior to the start of the event. Two or more delegates may
not ‘share’ a place at an event. Please make separate bookings for each delegate.
Cancellation: If you wish to cancel your attendance at an event and you are unable to send
a substitute, then we will refund/credit 50% of the due fee less a £50 administration charge,
providing that cancellation is made in writing and received at least 28 days prior to the start of the
event. Regretfully cancellation after this time cannot be accepted. We will however provide the
conferences documentation via the Document Portal to any delegate who has paid but is unable
to attend for any reason. Due to the interactive nature of the Briefings we are not normally able to
provide documentation in these circumstances. We cannot accept cancellations of orders placed
for Documentation or the Document Portal as these are reproduced specifically to order. If we
have to cancel the event for any reason, then we will make a full refund immediately, but disclaim
any further liability.
Alterations: It may become necessary for us to make alterations to the content, speakers, timing,
venue or date of the event compared to the advertised programme.
Privacy policy / Opt Out: For full details on our privacy policy please go to
http://smi-online.co.uk/privacy-legals/privacy-policy. If you no longer wish to receive email
updates you can opt out by going to the following webpage http://www.smi-online.co.uk/opt-out
Terms and Conditions of Booking
DELEGATE DETAILS
VENUE Hyatt Regency, Mission Bay, San Diego, CA, USA
□ Please contact me to book my hotel
Alternatively call us on +44 (0) 870 9090 711,
email: events@smi-online.co.uk or fax +44 (0) 870 9090 712
FAX your booking form to +44 (0) 870 9090 712
PHONE on +44 (0) 870 9090 711
POST your booking form to: Events Team, SMi Group Ltd,
Ground Floor, India House, 45 Curlew Street, London SE1 2ND